reassess for any new symptoms (edema, pericardial effusion signs, unexplained fatigue) Ongoing: Annual metabolic panel if both agents are continued long-term
Consistent technique matters more than perfect technique
An important regulatory note: On December 22, 2025, the FDA approved Novo Nordisk's Wegovy tablet (oral semaglutide 25 mg) as the first oral GLP-1 receptor agonist for chronic weight management, with a national launch in January 2026
Why Receptor Activity Matters The difference between semaglutide, tirzepatide, and retatrutide is not just branding
Individuals were excluded if they met any of the following criteria: chronic liver disease other than NAFLD, including alcohol, viral, drug-induced, autoimmune and genetic diseases, liver cirrhosis, or clinical diagnosis of hepatic decompensation (such as oesophageal varices or ascites)
Whether you need a bacteriostatic-water-reconstitution-solution-10ml or a larger 30ml vial for extensive studies, we are here to provide the quality assurance you need